Skip to main content
Henry Sacks, MD, Geriatrics, New York, NY

Henry S Sacks MD


Profe, Biomathematical Sciences, Icahn School of Medicine at Mount Sinai

Join to View Full Profile
  • 19 E 98th StBox 1042New York, NY 10029

  • Phone+1 212-241-7856

  • Fax+1 212-860-4607

Dr. Sacks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Connecticut
    University of ConnecticutFellowship, Infectious Disease, 1977 - 1979
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 1975 - 1977
  • Albany Medical College
    Albany Medical CollegeClass of 1975

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1979 - 2024
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Why Do September 11 First Responders Have a High Cancer Rate?
    Why Do September 11 First Responders Have a High Cancer Rate?July 28th, 2020
  • Sept. 11 Responders May Be at Heightened Risk of Developing Leukemia
    Sept. 11 Responders May Be at Heightened Risk of Developing LeukemiaJanuary 14th, 2020

Grant Support

  • Meta-Analysis Of CAM Therapies For HIVNational Center For Complementary &Alternative Medicine2010–2012
  • Effects Of A Dietary Supplement On Non-Small Cell Lung Cancer PatientsNational Center For Research Resources2009
  • Women'S Interagency HIV Study(Wihs)National Center For Research Resources2007
  • A Pilot Study Of Silymarin In Patients With HIV And HCVNational Center For Research Resources2005–2007
  • Women'S Interagency HIV Study(Wihs) (National Center For Research Resources2006
  • WIHS Cardiovascular ComponentNational Center For Research Resources2006
  • Prolong The Survival Of Nscl Patients By A PhytomixNational Center For Complementary &Alternative Medicine2004–2006
  • Women'S Interagency HIV Study (WIHS)National Center For Research Resources2005
  • Pilot Trial Of Silymarin In Patients With HCV And HIVNational Institute Of Nursing Research2004–2005
  • Leadership Award In Complementary And Alternative MedicNational Center For Complementary &Alternative Medicine2001–2005
  • Collaborative HIV/AIDS Development Project IndiaNational Center For Complementary &Alternative Medicine2003–2004
  • Protease Inhibitor/Methadone Metabolism In HIV InfectionNational Center For Research Resources2000–2002
  • PI &Nnrti In HIV InfectionNational Center For Research Resources2000–2002
  • Phase III Trial Of Efavirenz Or Nelfinavir Lamivudine &ZidovudineNational Center For Research Resources2000–2002
  • ACTG 323--Fluconazole As Chronic Supp. Therapy Vs. Episodic Therapy In HIV+ PTSNational Center For Research Resources2000–2002
  • ACTG 309 Pharmacokinetics Of Antituberculosis Agents In HIV InfectedNational Center For Research Resources2000–2002
  • ACTG 398 Phase II Trial Of Amprenavir Abacavir, Efavirenz &AdefovirNational Center For Research Resources1999–2002
  • ACTG 372 Phase II Study Of Prolongation Of Virologic Rollover For ACTNational Center For Research Resources1999–2002
  • ACTG 362 Trial To Determine Efficacy Of Azithromycin ProphylaxisNational Center For Research Resources1999–2002
  • ACTG 328--Study Of Intermt. Rhil-2 Compared To HaartNational Center For Research Resources1999–2002
  • ACTG 301 Trial Of Memantine For AIDS Dementia Complex (ADC)National Center For Research Resources1999–2002
  • ACTG 291--Trial Of RU Human Nerve GF In HIV Assoc. Perph. NeuropathyNational Center For Research Resources1999–2002
  • ACTG 364--Comparison Of The Virologic Efficacy Of Nelfinavir AND/OR DMP 266National Center For Research Resources1998–2002
  • Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–2001
  • Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Viral Activation Transfusion StudyDivision Of Blood Diseases And Resources1995–2001
  • Phase III Trial Of Efavirenz Or Nelfinavir , Lamivudine / ZidovudineNational Center For Research Resources1999
  • Pharmacokinetics Of Antituberculosis Agents In HIV Infected PersonsNational Center For Research Resources1999
  • Fluconazole As Supp. Therapy Vs. Episodic Therapy In HIV+ PTSNational Center For Research Resources1999
  • Women'S Interagency HIV Study (WIHS)National Center For Research Resources1998–1999
  • ACTG 368--Phase II Trial Of 1592U89 In Combination With Indinavir SulfateNational Center For Research Resources1998–1999
  • Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1997–1999
  • ACTG 320--Study Of Indinavir Sulfatae With OPEN Label Zidovudine &LamivudineNational Center For Research Resources1997–1999
  • ACTG 302--Virologic Responses To New Nucleoside Regimens After Prolonged ZDVNational Center For Research Resources1997–1999
  • ACTG 288--Follow UP Of Women Participating In ACTG 076National Center For Research Resources1997–1999
  • ACTG 254--Micronized Atovaquone &Azithromycin VS Trimethoprim/SulfamethaxzoleNational Center For Research Resources1997–1999
  • ACTG 245--Combination Antiretroviral Therapy In Children &Adolescents With HIVNational Center For Research Resources1997–1999
  • ACTG 219--Multicenter Trial Of The AIDS Clinical Trials GroupNational Center For Research Resources1997–1999
  • ACTG 200--A Preenrollment Protocol For HIV Infected AdolescentsNational Center For Research Resources1997–1999
  • ACTG 185--Phase Iii--Hivig For Prevention Of Maternal/Fetal HIV TransmissionNational Center For Research Resources1997–1999
  • Randomized Comparative Study Of Combined ZDV 3TC VS DDI Monotherapy VS Zdv/DdiNational Center For Research Resources1996–1999
  • ACTG 328--Phase II Study Of Intermittent Recombinant Human Interleukin 2National Center For Research Resources1998
  • ACTG 323--Phase IV Randomized Study Of The Use Of FluconazoleNational Center For Research Resources1998
  • ACTG 291--Phase II Trial Of Recombinant Human Nerve Growth FactorNational Center For Research Resources1997–1998
  • ACTG 261--Phase II Double Blind Study Of Delavirdine, Zidovudine, And DidanosineNational Center For Research Resources1997
  • ACTG 251--Thalidomide For Treatment Of Oral And Esophageal UlcersNational Center For Research Resources1997
  • ACTG 250--Phase I Study--Nevirapine In HIV I Infected Pregnant Women And NeonatesNational Center For Research Resources1997
  • ACTG 243--Phase II Study Comparing Antiretroviral Therapy Alone Or With ARA-CNational Center For Research Resources1997
  • ACTG 242--Phase II/III Double Blind Study Of Amitriptyline And MexiletineNational Center For Research Resources1997
  • ACTG 240--Randomized Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1997
  • ACTG 222--Treatment Of Mycobacterium Tuberculosis In HIV InfectionNational Center For Research Resources1997
  • ACTG 215--Phase I Study Of Tnp470 In Treatment Of AIDS Associated Kaposis SarcomaNational Center For Research Resources1997
  • ACTG 206--Randomized Phase II Trial Of Interferon With Didanosine In Kaposis SarcNational Center For Research Resources1997
  • ACTG 175--Monotherapy VS Combination Therapy With Nucleoside Analogues In HIVNational Center For Research Resources1997
  • ACTG 076--Safety &Tolerance Of ZDV For Prevention Of Maternal/Fetal HIV InfectioNational Center For Research Resources1997
  • Womens Interagency HIV StudyNational Center For Research Resources1996–1997
  • Four-Arm Study Comparing Combination To Monthly Alternating Nucleoside TherapyNational Center For Research Resources1996–1997
  • Early Diagnosis Of Pediatric HIV InfectionNational Center For Research Resources1993–1997
  • Pediatric AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1996
  • Two Arm Study Micronized Atovaquone Azithromycin VS Trimethoprim/SulfamethaxzoleNational Center For Research Resources1996
  • Randomized Double Blind Trial Of Bw256u87 ProphylaxisNational Center For Research Resources1996
  • Randomized Comparative Study Of Daily Dapsone And Daily Atovaquone Against PCPNational Center For Research Resources1996
  • Phase III Randomized--Hivig For Prevention Of Maternal Fetal HIV TransmissionNational Center For Research Resources1996
  • Phase III Randomized Trial Of Low Dose M Bacod Chemotherapy VS Standard DoseNational Center For Research Resources1996
  • Phase II/III Double Blind Study Of Amitriptyline And Mexiletine--Hiv InfectionNational Center For Research Resources1996
  • Phase II Multicenter Study Comparing Antiretroviral Therapy Alone To ARACNational Center For Research Resources1996
  • Phase II Double Blind Study Of Delavirdine, Zidovudine, And DidanosineNational Center For Research Resources1996
  • Phase I Study--Nevirapine In HIV I Infected Pregnant Women And NeonatesNational Center For Research Resources1996
  • Phase I Study Of Tnp470 In The Treatment Of AIDS Associated Kaposis SarcomaNational Center For Research Resources1996
  • Follow UP Of Women Participating In ACTG 076National Center For Research Resources1996
  • Combination Of Zidovudine, Didanosine, And Double Blinded NevirapineNational Center For Research Resources1996
  • Combination Antiretroviral Therapy In Children &Adolescents With Advanced HIVNational Center For Research Resources1996
  • A Randomized Phase II Trial Of Interferon With Didanosine In Kaposi'S SarcomaNational Center For Research Resources1996
  • Treatment Of Mycobacterium Tuberculosis In HIV InfectionNational Center For Research Resources1995–1996
  • Thalidomide For Treatment Of Ulcers And HIV ViremiaNational Center For Research Resources1995–1996
  • Safety &Tolerance Of ZDV For Prevention Of Maternal-Fetal HIV InfectionNational Center For Research Resources1995–1996
  • Randomized Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1995–1996
  • Multicenter Trial Of The AIDS Clinical Trials GroupNational Center For Research Resources1995–1996
  • Trial Of ZDV VS DDI VS Zdv+Ddi In Symptomatic HIV Infected ChildrenNational Center For Research Resources1994–1996
  • Study To Evaluate Activity Of Dideoxycytidine In Combination With ZidovudineNational Center For Research Resources1994–1996
  • DDC Alone Or Ddc/Zdv Combination VS Zidovudine Alone In Patients With HIVNational Center For Research Resources1994–1996
  • Clarithromycin VS Rifabutin VS Combination Of Clarithromycin PLUS RifabutinNational Center For Research Resources1994–1996
  • Pediatric AIDS Clinical ResearchNational Institute Of Allergy And Infectious Diseases1993–1996
  • Monotherapy VS Combination Therapy With Nucleoside Analogues In HIV PersonsNational Center For Research Resources1993–1996
  • Double Blind Comparison Of ZDV VS D4T For Patients With HIV InfectionNational Center For Research Resources1993–1996
  • Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–1996
  • Phase II Double-Blind Study Of Sc-49483 In Combination With ZidovudineNational Center For Research Resources1995
  • Phase II Double-Blind Study Of Delavirdine, Zidovudine, And DidanosineNational Center For Research Resources1995
  • Combination Of Zidovudine, Didanosine, And Double-Blinded NevirapineNational Center For Research Resources1995
  • A Randomized Phase 11 Trial Of Interferon With Didanosine In Kaposi'S SarcomaNational Center For Research Resources1995
  • Meta Analysis Of The AIDS LiteratureNational Institute Of Mental Health1994–1995
  • AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
  • Tolerance Of High VS Low Dose Zidovudine Administered To Children With HIVNational Center For Research Resources1994–1995
  • Three-Arm Study Comparing Combination To Monthly Alternating Nucleoside TherapyNational Center For Research Resources1994–1995
  • Safety And Efficacy Of ZDV For Asymptomatic HIV Infected IndividualsNational Center For Research Resources1994–1995
  • Randomized Double-Blind Trial Of BW 256u87 ProphylaxisNational Center For Research Resources1994–1995
  • Pediatric AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1993–1995
  • Trial Of Nimodipine For AIDS Dementia Complex With ZidovudineNational Center For Research Resources1993–1995
  • Feasibility Of Fluconazole For Relapse Of Histoplasmosis In Patients With AIDSNational Center For Research Resources1993–1995
  • Safety &Tolerance Of Oral Zidovudine In Hiv-Infected Pregnant Women TNational Center For Research Resources1994
  • Evaluation Of SQ 32,756 (Bv-Arau) VS Acyclovir In The Treatment Of Herpes ZosterNational Center For Research Resources1994
  • Combination Of Zidovudine, Didanosine, And Doubl-Blinded NevirapineNational Center For Research Resources1994
  • A Randomized Phase 11 Trial Of Interferon With Didanosine...Kaposi'S SarcomaNational Center For Research Resources1994
  • Trial Of 2',3'-Dideoxyinosine In Children With Symptomatic HIVNational Center For Research Resources1993–1994
  • Rifampin, Ciprofloxacin,...Mycobacterium Avium Infection In HIV InfectionNational Center For Research Resources1993–1994
  • Prophylaxis Against MTB In Patients Infected With HIVNational Center For Research Resources1993–1994
  • Combination Chemotherapy And DDI Or DDC In The Treatment Of Kaposi'S SarcomaNational Center For Research Resources1993–1994
  • Phase II Study Comparing 2'3'-Ddi And Zidovudine Therapy In PTS With AIDS Or ARCNational Center For Research Resources1992–1994
  • Dapsone/Trimethoprim &Clindamycin/Primaquine VS Trimethoprim/SulfamethoxazoleNational Center For Research Resources1992–1994
  • Bmy-27857 (2'3'-Didehydro-3'-Deoxythymidine, D4t) Administered To HIV+ PatientsNational Center For Research Resources1992–1994
  • Early Diagnosis Of Pediatric HIV InfectionNational Institute Of Allergy And Infectious Diseases1991–1994
  • Gamma Globulin And AZT In Children With HIV InfectionNational Center For Research Resources1990–1994
  • Short-Term Research TrainingNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1994
  • Trial Of Zvd VS DDI VS Zvd+Ddi In Symptomatic HIV Infected ChildrenNational Center For Research Resources1993
  • Safety And Tolerance Of Oral Zidovudine In Pregnancy HIV Infected WomenNational Center For Research Resources1993
  • Pyrimethamine Pharmacokinetics In HIV+ Patients Seropotive For T. GondiNational Center For Research Resources1993
  • 2'3'-Dideoxyinosine And Zidovudine In The Therapy Of Patients With AIDS Or ARCNational Center For Research Resources1993
  • Two Doses Of 2', Or 3'-Ddc In Treatment Of Children Intolerant To ZDVNational Center For Research Resources1992–1993
  • Randomized Study Of DDC Alone Or Ddc/Zdv Combination VS Zidovudine AloneNational Center For Research Resources1992–1993
  • Primary Prophylaxis Of Cerebral Toxoplasmosis In Hiv-Infected PatientsNational Center For Research Resources1992–1993
  • Phase I Safety And Pharmacokinetics Study Of D4T In Patients With AIDS Or ARCNational Center For Research Resources1992–1993
  • High VS Low Dose Zidovudine Administered To Children With HIVNational Center For Research Resources1992–1993
  • Meta-Analysis Of The AIDS LiteratureNational Institute Of Mental Health1991–1993
  • Safety And Efficacy Of Zvd For Asymptomatic HIV Infected IndividualsNational Center For Research Resources1991–1993
  • Potential Of Low Dose Therapy With ZDV And Interferon Alpha 2ANational Center For Research Resources1991–1993
  • Efficacy Of 2'3'Ddi Given Orally 2/Day To Patients With AIDS Or ARCNational Center For Research Resources1991–1993
  • Anti-Pneumocystis Agents PLUS ZDV For Prevention Of Serious InfectionsNational Center For Research Resources1991–1993
  • Establishment Of AIDS Treatment Evaluation UnitNational Institute Of Allergy And Infectious Diseases1992
  • Pyrimethamine Pharmacokinetics In HIV+ Patients Seropotivie For T GondiNational Center For Research Resources1992
  • Comparison Of 2',3'-Ddi Given Orally 2/Day To Patients With AIDS Or ARCNational Center For Research Resources1992
  • AZT In Treatment Of HIV Infection In Hemophilic PatientsNational Center For Research Resources1992
  • Safety/Efficicy Of ZDV In Therapy Of Patients With Early ARCNational Center For Research Resources1991–1992
  • Pediatric AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1988–1992
  • Phase II Study Comparing 2'3'-Ddi And Zivoduine Therapy In PTS With AIDS Or ARCNational Center For Research Resources1991
  • Foscarnet Salvage Therapy For AIDS Patients With Sight Threatening CMV RetinitisNational Center For Research Resources1991
  • Comparison Of 2',3'-Ddi Given Oraly 2/Day To Patients With AIDS Or ARCNational Center For Research Resources1991
  • Fluconqzole And Amphotaercin B In AIDS Patients With Crytococcal MeningitisNational Center For Research Resources1990–1991
  • Placebo Controlled Trial To Evaluate ZDV In Treatment Of HIV In Hemophilic PTSNational Center For Research Resources1989–1991
  • PCP In Aids--Trimetrexae With Leacovorin CA Rescue VS Trimethoprim/SulfamethoxNational Center For Research Resources1989–1991
  • The Establishment Of AIDS Treatment Evaluation UnitNational Institute Of Allergy And Infectious Diseases1988–1991
  • Phase I Safety &Pharmacokinetics Of D4T In Patients With AIDS Or ARCNational Center For Research Resources1990
  • Phase ONE Study Of As-101 In Patients With AIDS And ARCNational Center For Research Resources1989–1990
  • PCP In Aids--Aerosolized Pentamidine VS Parental/Oral Trimethrapin-SulfamethoxNational Center For Research Resources1989
  • Fluconqzole And Amphotaercin B In AIDS PTS. With Crytococcal MeningitisNational Center For Research Resources1989
  • Ateu 2:Azt In Treatment Of HIV Infection With AIDS Post First EpisodeNational Center For Research Resources1988
  • Aeu1:Azt In Treatment Of HIV Infection With Aids-Associated Kaposi'S SarcomaNational Center For Research Resources1988

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: